73 related articles for article (PubMed ID: 22236543)
1. Prolyl hydroxylase domain 2 protein is a strong prognostic marker in human gastric cancer.
Kamphues C; Wittschieber D; Klauschen F; Kasajima A; Dietel M; Schmidt SC; Glanemann M; Bahra M; Neuhaus P; Weichert W; Stenzinger A
Pathobiology; 2012; 79(1):11-7. PubMed ID: 22236543
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
[TBL] [Abstract][Full Text] [Related]
4. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
[TBL] [Abstract][Full Text] [Related]
5. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.
Chou YY; Jeng YM; Lee TT; Hu FC; Kao HL; Lin WC; Lai PL; Hu RH; Yuan RH
Ann Surg Oncol; 2007 Oct; 14(10):2748-58. PubMed ID: 17680316
[TBL] [Abstract][Full Text] [Related]
6. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the prognostic value of a panel of tissue tumor markers and established clinicopathological factors in patients with gastric cancer.
Wiksten JP; Lundin J; Nordling S; Kokkola A; Haglund C
Anticancer Res; 2008; 28(4C):2279-87. PubMed ID: 18751407
[TBL] [Abstract][Full Text] [Related]
8. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
9. Low expression of prolyl hydroxylase 2 is associated with tumor grade and poor prognosis in patients with colorectal cancer.
Xie G; Zheng L; Ou J; Huang H; He J; Li J; Pan F; Liang H
Exp Biol Med (Maywood); 2012 Jul; 237(7):860-6. PubMed ID: 22802519
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer.
Santini D; Vincenzi B; Fratto ME; Perrone G; Lai R; Catalano V; Cass C; Ruffini PA; Spoto C; Muretto P; Rizzo S; Muda AO; Mackey JR; Russo A; Tonini G; Graziano F
J Cell Physiol; 2010 May; 223(2):384-8. PubMed ID: 20082300
[TBL] [Abstract][Full Text] [Related]
11. Neurotrophic receptor, tropomyosin-related kinase B as an independent prognostic marker in gastric cancer patients.
Tanaka K; Mohri Y; Nishioka J; Kobayashi M; Ohi M; Miki C; Tonouchi H; Nobori T; Kusunoki M
J Surg Oncol; 2009 Apr; 99(5):307-10. PubMed ID: 19170129
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery.
Wen Y; Wang Q; Zhou C; Yan D; Qiu G; Yang C; Tang H; Peng Z
Ann Surg Oncol; 2011 Dec; 18(13):3858-67. PubMed ID: 21442347
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of N-cadherin expression in gastric cancer.
Kamikihara T; Ishigami S; Arigami T; Matsumoto M; Okumura H; Uchikado Y; Kita Y; Kurahara H; Kijima Y; Ueno S; Natsugoe S
Pathol Int; 2012 Mar; 62(3):161-6. PubMed ID: 22360503
[TBL] [Abstract][Full Text] [Related]
14. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
[TBL] [Abstract][Full Text] [Related]
15. Expression of key hypoxia sensing prolyl-hydroxylases PHD1, -2 and -3 in pancreaticobiliary cancer.
Gossage L; Zaitoun A; Fareed KR; Turley H; Aloysius M; Lobo DN; Harris AL; Madhusudan S
Histopathology; 2010 Jun; 56(7):908-20. PubMed ID: 20497244
[TBL] [Abstract][Full Text] [Related]
16. High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: comparison with non-cancerous lesions.
Ichinoe M; Mikami T; Yoshida T; Igawa I; Tsuruta T; Nakada N; Anzai N; Suzuki Y; Endou H; Okayasu I
Pathol Int; 2011 May; 61(5):281-9. PubMed ID: 21501294
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical evaluation of the tumor neoangiogenesis as a prognostic factor for gastric cancers.
Lazăr D; Tăban S; Raica M; Sporea I; Cornianu M; Goldiş A; Vernic C
Rom J Morphol Embryol; 2008; 49(2):137-48. PubMed ID: 18516318
[TBL] [Abstract][Full Text] [Related]
18. Arp2/3 overexpression contributed to pathogenesis, growth and invasion of gastric carcinoma.
Zheng HC; Zheng YS; Li XH; Takahashi H; Hara T; Masuda S; Yang XH; Guan YF; Takano Y
Anticancer Res; 2008; 28(4B):2225-32. PubMed ID: 18751399
[TBL] [Abstract][Full Text] [Related]
19. Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma.
Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM
Ann Surg Oncol; 2007 Oct; 14(10):2721-9. PubMed ID: 17564748
[TBL] [Abstract][Full Text] [Related]
20. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]